Volume : 13, Issue : 07, July – 2026
Title:
COLCHICINE IN THE MANAGEMENT OF PERICARDITIS: A COMPREHENSIVE REVIEW
Authors :
Asma Anjum,Ayesha Batool ,Fouzia Khan
Abstract :
Pericarditis is a frequently encountered inflammatory cardiac disorder with a significant risk of recurrence and morbidity. Conventional treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) alone has been associated with suboptimal outcomes, particularly in recurrent cases. Colchicine, a well-established anti-inflammatory agent, has emerged as an effective adjunct therapy in the management of both acute and recurrent pericarditis. This review summarizes the pathophysiology of pericarditis, pharmacological properties of colchicine, evidence from clinical trials, therapeutic indications, dosing strategies, safety considerations, and current guideline recommendations. Data from multiple randomized controlled trials demonstrate that colchicine significantly reduces recurrence rates, symptom persistence, and hospitalization. Its integration into standard treatment protocols has improved overall patient outcomes. Careful patient selection and monitoring remain essential to optimize benefits and minimize adverse effects.
Keywords: Colchicine, Pericarditis, Recurrent pericarditis, Anti-inflammatory therapy, Cardiovascular pharmacotherapy
Cite This Article:
Please cite this article in press Asma Anjum et al., Colchicine In The Management Of Pericarditis: A Comprehensive Review, Indo Am. J. P. Sci, 2026; 13(07).
REFERENCES:
1. Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–1528.
2. Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (CORP). Ann Intern Med. 2011;155:409–414.
3. Imazio M, Bobbio M, Cecchi E, et al. Colchicine in acute pericarditis (COPE trial). Circulation. 2005;112:2012–2016.
4. Imazio M, Belli R, Brucato A, et al. Efficacy of colchicine in recurrent pericarditis (CORP-2). Lancet. 2014;383:2232–2237.
5. Adler Y, Charron P, Imazio M, et al. ESC Guidelines for pericardial diseases. Eur Heart J. 2015;36:2921–2964.
6. Imazio M, Spodick DH, Brucato A, et al. Management of pericardial diseases. Circulation. 2010;121:916–928.
7. Khandaker MH, Espinosa RE, Nishimura RA, et al. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85:572–593.
8. Imazio M, Cooper LT. Management of myopericarditis. Expert Rev Cardiovasc Ther. 2013;11:193–201.




